Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

FHS
June 3, 2024
4:18 pm

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Optimind Pharma – Private Placement | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – July 3, 2024) – Optimind Pharma Corp. (CSE: OMND) (the “Optimind” or the “Company”) announces a proposed private placement. The Company

July 8, 2024

CDC: Kids’ Routine Vaccinations Prevented Half a Billion Illnesses Since 1994

Over the past 30 years, routine childhood vaccinations in the U.S. prevented hundreds of millions of illnesses and more than a million deaths, while saving

August 9, 2024

Inflammaging: The hidden cause of aging and age-related conditions

University of Virginia School of Medicine researchers have discovered a key driver of chronic inflammation that accelerates aging.

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.